Open Access 01-08-2021 | Ketoacidosis | Correction
Correction to: Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study
Published in: Advances in Therapy | Issue 8/2021
Login to get access